High Dose Chemotherapy and Autologous Transplant for Breast Cancer

High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00186641

Enrollment

203

Registered

2005-09-16

Start date

Unknown

Completion date

2008-02-08

Last updated

2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graft vs Host Disease

Keywords

chronic Graft vs Host Disease

Brief summary

To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy

Interventions

PROCEDUREhigh dose chemo and auto hematopoietic cell transplant

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Stage II, III or IV breast cancer * chemosensitive * adequate organ function

Exclusion criteria

* prior transplant, * life threatening disease * brain metastases

Design outcomes

Primary

Measure	Time frame
Survival	—

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORGinna Laport, MD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026